ENVA Q1 2026 Earnings EPS Beats Estimates Shares Rise AKTX Q1 2026 Earnings Clinical Progress Fuels Massive Rally Despite WiderThanExpected Loss NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase ITRN Q4 2025 Earnings EPS Beats Estimates Stock Rises 316 BHFAM Q1 2026 Earnings Preferred Stock EPS Falls Short of Expectations Amid Mixed Operating Environment vTv Therapeutics Inc VTVT Slips 3 as Resistance Holds Traders Eye Support Test Green Brick Partners GRBK Edges Higher as Homebuilder Shows Resilience Near Resistance Clorox CLX Holds Steady Near 95 as Traders Eye Key Support and Resistance Levels Shoulder Innovations SI Slips 179 as Key Support Levels Are Tested UTMD Q1 2024 Earnings Solid EPS Performance Amidst Cautious Market Reaction